BIOMAT Database Logo BIOMAT Database Logo

Thyroxine replacement in an animal model of congenital hypothyroidism. 2007

Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
School of Psychology, University of Ulster at Jordanstown, Newtownabbey, Northern Ireland.

This study examined the effects of thyroxine (T(4)) treatment on spatial learning and memory in congenitally hypothyroid (CH) rats. Forty CH male offspring of methimazole-treated dams were randomly divided into three groups: no T(4) (vehicle) treatment (n=12), T(4) treatment commencing on postnatal day (P-) 7 (n=14), and T(4) treatment commencing on P-21 (n=14). Normal male rats were used as a control group (n=14). T(4) was administered daily (sc, 0.02 microg/g) to the treatment groups for 30 days. A water-maze was used to assess behaviour at 42, 70 and 98 days of age. T(4) treatment beginning at P-7 improved learning and memory associated with CH at 70 and 98 days of age but T(4) treatment beginning at P-21 did not improve CH-impaired learning and memory.

UI MeSH Term Description Entries
D008297 Male Males
D008713 Methimazole A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. Methymazol,Thiamazole,1-Methyl-2-mercaptoimidazole,Favistan,Mercasolyl,Mercazol,Mercazole,Mercazolyl,Merkazolil,Methizol,Methylmercaptoimidazole,Metisol,Metizol,Strumazol,Tapazole,Thiamazol Henning,Thiamazol Hexal,Thimazol,Thyrozol,Tiamazol,Tirodril,1 Methyl 2 mercaptoimidazole,Henning, Thiamazol,Hexal, Thiamazol
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D003409 Congenital Hypothyroidism A condition in infancy or early childhood due to an in-utero deficiency of THYROID HORMONES that can be caused by genetic or environmental factors, such as thyroid dysgenesis or HYPOTHYROIDISM in infants of mothers treated with THIOURACIL during pregnancy. Endemic cretinism is the result of iodine deficiency. Clinical symptoms include severe MENTAL RETARDATION, impaired skeletal development, short stature, and MYXEDEMA. Cretinism,Myxedema, Congenital,Endemic Cretinism,Fetal Iodine Deficiency Disorder,Cretinism, Endemic,Hypothyroidism, Congenital
D003423 Critical Period, Psychological A specific stage in animal and human development during which certain types of behavior normally are shaped and molded for life. Critical Period, Psychology,Critical Periods, Psychological,Critical Periods, Psychology,Period, Psychological Critical,Period, Psychology Critical,Psychological Critical Period
D004193 Discrimination Learning Learning that is manifested in the ability to respond differentially to various stimuli. Discriminative Learning,Discrimination Learnings,Discriminative Learnings,Learning, Discrimination,Learning, Discriminative
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females

Related Publications

Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Evaluation of L-thyroxine replacement therapy in children with congenital hypothyroidism.
December 1991, Journal of endocrinological investigation,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
[Combined l-thyroxine and l-triiodothyronine replacement therapy in congenital hypothyroidism].
May 2013, Orvosi hetilap,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Basal Serum Thyroxine Level should Guide Initial Thyroxine Replacement Dose in Neonates with Congenital Hypothyroidism
August 2021, Journal of clinical research in pediatric endocrinology,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Thyroxine replacement in post-radioiodine hypothyroidism.
February 1991, Clinical endocrinology,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Maternal thyroxine and congenital hypothyroidism.
July 1989, The New England journal of medicine,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Thyroxine dose for congenital hypothyroidism.
October 1995, Clinical pediatrics,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Effect of prolonged discontinuation of L-thyroxine replacement in a child with congenital hypothyroidism.
January 2012, Case reports in endocrinology,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Therapeutic dilemma with thyroxine replacement in hypothyroidism.
September 1994, Archives of internal medicine,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Optimisation of thyroxine dose in congenital hypothyroidism.
February 2002, Archives of disease in childhood,
Rosemary E Reid, and Eun-Mee Kim, and Deaglan Page, and Shane M O'Mara, and Eugene O'Hare
Appropriate replacement dose of thyroxine in primary hypothyroidism.
January 1987, Acta medica Scandinavica,
Copied contents to your clipboard!